
PetIQ PETQ
Annual report 2023
added 02-29-2024
PetIQ Current Ratio 2011-2025 | PETQ
Annual Current Ratio PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.4 | 2.54 | 3.24 | 5.99 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.99 | 2.4 | 3.54 |
Current Ratio of other stocks in the Drug manufacturers industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | ||
|
Assertio Holdings
ASRT
|
1.93 | $ 0.74 | -3.53 % | $ 52.6 M | ||
|
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
2.13 | $ 1.69 | -3.13 % | $ 182 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
1.78 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | ||
|
Cronos Group
CRON
|
6.63 | $ 3.06 | -6.57 % | $ 1.61 B | ||
|
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | ||
|
Aurora Cannabis
ACB
|
3.49 | $ 5.18 | -4.17 % | $ 86.3 M | ||
|
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
9.82 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M | ||
|
DURECT Corporation
DRRX
|
1.95 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
1.77 | - | - | $ 28.9 M | ||
|
Emergent BioSolutions
EBS
|
1.55 | $ 11.76 | 2.98 % | $ 602 M | ||
|
Evoke Pharma
EVOK
|
0.733 | $ 10.97 | 0.18 % | $ 36.7 M | ||
|
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
1.82 | $ 21.39 | 0.14 % | $ 2.04 B | ||
|
Evolus
EOLS
|
1.02 | $ 7.17 | 1.85 % | $ 445 M | ||
|
Harrow Health
HROW
|
1.29 | $ 46.47 | -1.25 % | $ 1.52 B | ||
|
China Pharma Holdings
CPHI
|
2.09 | $ 1.55 | -0.64 % | $ 27.1 M | ||
|
Bausch Health Companies
BHC
|
0.997 | $ 6.83 | -1.37 % | $ 2.49 B | ||
|
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | ||
|
Organogenesis Holdings
ORGO
|
4.42 | $ 4.86 | 0.73 % | $ 640 M | ||
|
OrganiGram Holdings
OGI
|
4 | $ 1.82 | -5.36 % | $ 402 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
1.43 | $ 3.03 | 19.57 % | $ 42.6 M | ||
|
Pacira BioSciences
PCRX
|
2 | $ 26.71 | 1.6 % | $ 1.24 B | ||
|
Neoleukin Therapeutics
NLTX
|
6.09 | - | - | $ 193 M | ||
|
Rockwell Medical
RMTI
|
1.69 | $ 0.88 | -5.09 % | $ 20.5 M | ||
|
Solid Biosciences
SLDB
|
3.67 | $ 5.81 | -1.02 % | $ 237 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
1.48 | $ 3.45 | -3.96 % | $ 4.28 M | ||
|
Relmada Therapeutics
RLMD
|
8 | $ 4.32 | 6.4 % | $ 130 M | ||
|
Jupiter Wellness
JUPW
|
0.772 | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
1.81 | $ 12.85 | -2.17 % | $ 1.77 B | ||
|
ProPhase Labs
PRPH
|
3.65 | $ 0.11 | -2.7 % | $ 1.74 M | ||
|
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | ||
|
Sundial Growers
SNDL
|
6.25 | $ 2.02 | -8.68 % | $ 3.37 M | ||
|
OptiNose
OPTN
|
0.554 | - | - | $ 1.08 B | ||
|
Veru
VERU
|
2.15 | $ 2.43 | 0.41 % | $ 328 M | ||
|
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | ||
|
cbdMD
YCBD
|
1.23 | $ 1.4 | 14.75 % | $ 6.04 M | ||
|
SCYNEXIS
SCYX
|
2.32 | $ 0.64 | -1.21 % | $ 30.6 M | ||
|
Tricida
TCDA
|
1 | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
4.41 | $ 11.41 | -6.09 % | $ 7.05 B | ||
|
TherapeuticsMD
TXMD
|
3.09 | $ 1.69 | -3.43 % | $ 17.6 M | ||
|
Zomedica Corp.
ZOM
|
19.2 | - | -0.21 % | $ 98 M | ||
|
Viatris
VTRS
|
1.73 | $ 11.68 | 0.21 % | $ 14.2 B |